Morroniside ameliorates inflammatory skeletal muscle atrophy via inhibiting canonical and non-canonical NF-κB and regulating protein synthesis/degradation

No drug options exist for skeletal muscle atrophy in clinical, which poses a huge socio-economic burden, making development on drug interventions a general wellbeing need. Patients with a variety of pathologic conditions associated with skeletal muscle atrophy have systemically elevated inflammatory...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Xiangjiao, Tao, Jianguo, Qian, Yu, Feng, Feng, Hu, Xueqin, Xu, Taotao, Jin, Hongting, Ruan, Hongfeng, Zheng, Hou-Feng, Tong, Peijian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816435/
https://www.ncbi.nlm.nih.gov/pubmed/36618945
http://dx.doi.org/10.3389/fphar.2022.1056460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9816435/
https://www.ncbi.nlm.nih.gov/pubmed/36618945
http://dx.doi.org/10.3389/fphar.2022.1056460

Ejemplares similares